Simple FNI labs pinpoint high‑mortality MASLD fibrosis in type 2 diabetes, challenging FIB‑4 and sharpening MASH liver disease screening. An age-independent liver fibrosis marker outperformed 2 widely ...
FIB-4 score data were available for 16,585 patients (94.2% of the total SELECT population). All patients were stratified according to FIB-4 score for their predicted risk of substantial liver fibrosis ...
Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disorder worldwide and is increasingly recognized as a multisystem disease that elevates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results